Juniper
Publishers- JOJ Ophthalmology
Results
A total of 19 patients underwent the inferior fornix
suture stabilization procedure at the time of ectropion repair surgery.
The average age was 82.5 years old (Range: 63-95), 13 were male (68.4%)
and 6 were female (31.6%). Of the 19 patients included in the study, a
total of 24 eyes underwent the inferior fornix stabilization procedure
(5 OD, 9 OS, 5OU). The average number of postoperative follow-up visits
was 2.2 (Range: 1-4), and the average total follow-up length was 8.5
weeks (Range: 1-16). In 79.2 percent (19 of 24) of the cases, no
postoperative chemosis was noted following the ectropion repair in
combination with the inferior fornix stabilization procedure described
above. The incidence of chemosis noted postoperatively was 20.8 percent
(5 of 24). The following chemosis classification system described by
Weinfeld et al. [4] was used for classifying postoperative chemosis:
- Type 1 (acute mild) involves mild edema and inflammation, yellow and/or pink conjunctiva color, absent lagophthalmos, and less than three weeks duration.
- Type 2 (acute severe) involves severe edema and inflammation, yellow and/or pink conjunctiva color, lagophthalmos present laterally, and less than three weeks duration.
- Type 3 (subchronic) involves mild to severe edema, chronic inflammation, pink color, absent lagophthalmos, and duration of chemosis between three weeks and six months.
- Type 4 (subchronic because of lower lid malposition) involves severe edema, moderate to severe inflammation, pink color, lower lid malposition and/or ectropion, and duration lasting until lid malposition is corrected [4].
All five cases of postoperative chemosis were
classified as Type 1, acute mild. In all cases, chemosis ultimately
resolved without any permanent sequela. No secondary entropion was
observed in any case. All patients maintained good function, motility,
and cosmesis of lower eyelids, and physician and patient satisfaction
was achieved in all cases.
Discussion
This surgical technique may be used for preventing
postoperative chemosis, thus limiting the deleterious effects that
conjunctival edema may have on wound healing. Indications for this
chemosis limiting procedure may be for severe ectropion repair, patients
with high likelihood of ectropion repair failure, or those at high risk
for postoperative chemosis. Chemosis or severe lid instability on
preoperative physical exam, as well as a history of previous chronic
chemosis following ocular surgery may provide indication for inferior
fornix stabilization at the time of the initial surgery. Additionally,
this chemosis limiting procedure may be used for postoperative patients
who have chronic chemosis resistant to medical management requiring a
return to the operating room for surgical treatment of the conjunctival
edema.
Sutures have been used for correcting eyelid malrotation for centuries [11].
Snellen described the Snellen Suture Technique in 1869 for correcting
ectropion by passing a suture through the conjunctiva in the inferior
fornix and out the skin inferiorly, therefore rotating the eyelid
margin. Snellen used two horizontal mattress sutures about 3 mm apart
just inferior to the tarsus, nearest the margin of the eyelid. The first
was placed at the junction of the outer and middle third of the
conjunctiva, and the second at the junction of the inner and middle
third [1,12].
A modified Snellen suture technique was described by Laval and
Schneider and later by Barrett aimed at correcting inferior prolapsed
conjunctiva, differing from Snellen by incorporating the arcus
marginalis and inferior orbital rim [13,14]. This incorporation, however, resulted in an increased risk of secondary entropion [10,13].
Malone and Tse described a inferior fornix suture technique for
treating postoperative prolapsed conjunctiva using three double-armed
4-0 chromic gut sutures inserted in a horizontal mattress fashion to
invaginate prolapsed inferior forniceal conjunctiva. The suture needle
was passed through the dome of the prolapsed conjunctiva, into the
inferior cul-de-sac, and brought out through the skin 8-9mm below the
lash margin, and tied without a bolster. By not incorporating the arcus
marginalis and inferior orbital rim, and by passing the suture full
thickness through the eyelid, the likelihood of causing eyelid
malrotation was likely reduced [10].
Unlike the technique described by Malone and Tse, the inferior fornix
suture technique in this study was done at the time of the primary
surgery in a preemptive effort aimed at prevention of postoperative
chemosis and inferior fornix conjunctival prolapse in high risk
patients. Additionally, foam bolsters were used when tying the sutures
and the procedure did not include a temporary tarsorraphy.
This simple surgical procedure offers several
advantages over medical management alone. It can be used as a corrective
treatment for persistent chemosis, and also as a preventative measure
for those with a high likelihood of postoperative chemosis. Also,
preventing the inferior fornix conjunctiva from prolapsing or
repositioning intra operative prolapsed conjunctiva will minimize
exposure, inflammation, and epidermalization of the conjunctiva [10].
This study, however, has some limitations. The lack
of control arm comparing chemosis incidence following severe ectropion
repair without the proposed inferior fornix stabilization procedure
restricts us from comparing the natural history of chemosis independent
of the inferior fornix stabilization. Future studies of this technique
could be performed prospectively. We do, however, feel that this
technique significantly reduced the likelihood of postoperative chemosis
given that only 20.8 percent of severe ectropion repairs in patients
who were at high risk of postoperative chemosis actually manifested
chemosis, all of which were characterized as Type 1, acute mild.
Additionally, all cases of chemosis ultimately resolved without any
permanent sequela. We believe this surgical technique can be used as a
successful preventative measure for postoperative chemosis as well as
for a surgical treatment option of postoperative chemosis resistant to
conservative management.
Acknowledgment/Disclosure
The authors have no proprietary or commercial interest in any materials discussed in this article.
No comments:
Post a Comment